Latest News

  • INNOVATION

    25 Feb 2026

    Can AI Rethink How New Drugs Are Found?

  • PARTNERSHIPS

    24 Feb 2026

    Lilly Deepens AI Push in Obesity Drug Race

  • INVESTMENT

    23 Feb 2026

    Another Shot in the Obesity Gold Rush

  • MARKET TRENDS

    19 Feb 2026

    Precision Medicine Rises as Biomarkers Drive Change

Pfizer Steps Up Obesity Push With Metsera Deal

Pfizer corporate logo displayed outside office building

PARTNERSHIPS

17 Feb 2026

US drugmaker agrees multibillion-dollar acquisition to bolster metabolic pipeline and challenge leaders in weight-loss therapies

Illustration of a human liver showing cellular damage linked to metabolic disease

PARTNERSHIPS

20 Jan 2026

Roche’s 89bio Deal Heats Up the Race for MASH Drugs

Roche’s acquisition of 89bio signals rising confidence in late-stage MASH drugs and sharpens competition for metabolic liver disease treat...

Laboratory researcher pipetting samples during obesity drug development research

INSIGHTS

19 Jan 2026

A $160M Biotech Bet Points to Obesity Drugs’ Next Test

A newly funded startup is betting durability, not just weight loss, will define the next era of obesity drugs

Road sign displaying the words Fast Track against a blue sky

RESEARCH

16 Jan 2026

FDA Fast Tracks Dual-Action MASH Drug: Is Momentum Back?

FDA grants two expedited reviews to a dual-action MASH drug, reviving interest in metabolic approaches without signaling a policy overhaul

Lilly and Nimbus Therapeutics logos displayed to mark an obesity drug development partnership

PARTNERSHIPS

13 Jan 2026

Big Pharma’s Next Obesity Bet Comes in Pill Form

Drugmakers push oral obesity pills into late trials, aiming to move weight loss care beyond injections and into mass-market medicine

Eli Lilly corporate headquarters sign outside company office building

INVESTMENT

12 Jan 2026

Lilly’s Ventyx Deal Points to a Future Beyond Injections

Eli Lilly’s $1.2B Ventyx buy shows growing confidence in oral small-molecule drugs aimed at inflammation and long-term metabolic health

Oral weight loss pills with measuring tape illustrating shift in obesity treatment

MARKET TRENDS

8 Jan 2026

Oral Weight Loss Pills Are Shaking Up Metabolic Care

Oral obesity drugs are widening access, shifting pricing power, and forcing drugmakers and health platforms to rethink how metabolic care ...

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.